Lundbeck — Drug Prices & Medicare Spending
Lundbeck manufactures 3 drugs tracked by Medicare Part D with total spending of $590.0M.
3
Drugs Tracked
$590.0M
Medicare Spending
$1,096.65
Avg Cost/Claim
100%
Have Generics
Lundbeck Drugs — Ranked by Medicare Spending
| # | Drug | Generic Name | Cost/Claim | Generic? |
|---|---|---|---|---|
| 1 | Vyepti | Eptinezumab | $944.00 | Yes |
| 2 | Onfi | Clobazam | $718.00 | Yes |
| 3 | Sabril | Vigabatrin | $4,238.00 | Yes |
Frequently Asked Questions
Lundbeck manufactures 3 drugs tracked by Medicare Part D, with total annual spending of $590.0M.
Sabril (Vigabatrin) is the most expensive at $4,238.00 per claim.
3 of 3 Lundbeck drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.